Dimensional Fund Advisors
GNCA

Dimensional Fund Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

Dimensional Fund Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,641
Closed -$43K – 3350
2017
Q3 		$43K Sell
3,641
-2,640
-42% -$100K ﹤0.01% 3308
2017
Q2 		$262K Sell
6,281
-138
-2% -$6.64K ﹤0.01% 3177
2017
Q1 		$313K Hold
6,419
– – ﹤0.01% 3155
2016
Q4 		$212K Buy
6,419
+320
+5% +$10.5K ﹤0.01% 3196
2016
Q3 		$250K Buy
6,099
+1,749
+40% +$68.6K ﹤0.01% 3159
2016
Q2 		$143K Buy
+4,350
New +$159K ﹤0.01% 3209

Other funds holding GNCA

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Dimensional Fund Advisors's GNCA Position: Q4 2017 in Review

Dimensional Fund Advisors sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2017, closing a stake of 3,641 shares — an estimated $43K sold.

Dimensional Fund Advisors first reported a position in GNCA in Q2 2016 and held it in 6 quarters. The position peaked at $313K in Q1 2017. 56 funds tracked by Wall St. Rank hold GNCA as of Q4 2017.

  • Dimensional Fund Advisors reported no remaining Genocea Biosciences, Inc. position as of Q4 2017 after selling out during the quarter.
  • Dimensional Fund Advisors sold 3,641 Genocea Biosciences, Inc. shares in Q4 2017, an estimated $43K.
  • Dimensional Fund Advisors first reported a position in Genocea Biosciences, Inc. in Q2 2016 and held it in 6 quarters.
  • Dimensional Fund Advisors's Genocea Biosciences, Inc. position peaked at $313K in Q1 2017.
  • 56 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2017.

Based on Dimensional Fund Advisors's 13F filing for Q4 2017, filed 12 Feb 2018.